Multi-Cancer Early Detection

Cancer is a widespread disease that affects many people, so it’s important to stay vigilant and take proactive steps for your health. Today, there are many groundbreaking cancer detection test is available, such as the CancerScreenDx™ test and Galleri® test, and to name a few. It’s good at figuring out where the cancer started, which helps in diagnosing it.

Multi-cancer early detection (MCED) represents an innovative approach to cancer screening. It leverages advancements in genomic science and machine learning to revolutionize the way we detect cancer.


Should MCED tests be employed for general cancer screening, or would they be more suitable for specific populations? These populations might include individuals over a certain age or those at elevated risk of cancer due to genetics or particular exposures, such as workplace hazards.


Genetic testing provides valuable insights into an individual’s cancer risk. It involves the examination of specific genetic mutations in a person’s genes before they exhibit any disease symptoms. Typically, these tests use blood samples, although saliva or other tissues may also be used. It’s important to note that genetic tests do not detect the presence or absence of cancer itself. On the other hand, MCED tests utilize blood samples and are designed to identify potential cancer across multiple types simultaneously. If someone receives a positive MCED result, further follow-up testing is necessary to confirm the actual presence of cancer.

Comprehensive Cancer Detection: Learn the Capabilities of the Evolutionary Early Cancer Detection Test

Early Cancer Detection Test can find more than 85 types of cancer, even before you feel sick, using just one blood sample. This Early Cancer detection test is meant to be used along with other screening methods, especially for people who have a higher chance of getting cancer, like those who are 50 years old or older, or anyone with family history of cancer.

  • Technology: It uses a new technology called “targeted error correction sequencing” (TEC-Seq) to accurately find cancer-specific changes in circulating tumor DNA (ctDNA). It looks at a lot more genes than other tests, making it better at finding different types of cancer.
  • Benefits: The blood test offers notable advantages, detecting various cancers early for improved treatment outcomes and increased survival rates. With a simple, one-time blood draw, it provides a user-friendly experience. The test also delivers a personalized risk assessment based on individual genetic information, offering valuable insights. Additionally, the information provided assists in making informed decisions about the most appropriate course of treatment.
  • Potential Impact: Consult your healthcare provider to determine the most suitable test for you. The Early Cancer Detection Test could change how we find and manage cancer. By finding many types of cancer early, it could increase survival and lower healthcare costs.


Understanding the differences helps you make informed decisions about your health. The latest trends in Early Cancer detection test offer promising solutions for earlier diagnoses and improved outcomes. By combining the benefits of both cancer screening and early detection, we can enhance our fight against this widespread disease and empower individuals to take control of their health.

Functional medicine Malaysia doctor

Dr. Shirley Koeh
04 September 2023